本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2018/1/191 分钟阅读
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →